Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-06-19Clinical Trial Update: Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants [Phase 1, Phase 2]
This document summarizes a completed Phase 1/2 clinical trial evaluating antioxidants as treatment for newly diagnosed ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib [Phase 2]
This Phase 2 trial evaluated cediranib in combination with olaparib for ovarian cancer and has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Autologous OC-DC Vaccine in Ovarian Cancer [EARLY_Phase 1]
A Phase 1 study of an autologous OC-DC dendritic cell vaccine in ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer [Phase 2]
Phase 2 trial in ovarian cancer comparing ABT-888 (veliparib) in combination with temozolomide versus pegylated liposomal doxorubicin has co…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating apatinib for advanced ovarian cancer after failure of standard chemotherapy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer [Phase 2]
Phase 2 trial update of alisertib (MLN8237) in ovarian, fallopian tube, or peritoneal cancer following a prior MLN8237 plus paclitaxel Phase…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: EC17 for Intraoperative Imaging in Occult Ovarian Cancer [Phase 1]
A Phase 1 clinical trial evaluating EC17 as an intraoperative imaging agent for detecting occult ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer [Phase 2]
Clinical trial update noting the completion of a Phase 2 study evaluating a psychosexual intervention in patients with Stage I-III gynecolog…
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating pembrolizumab (Keytruda) plus chemotherapy versus chemotherapy alone in recurrent platinum-resistant ovarian canc…
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients [Phase 2]
Phase 2 trial evaluating metformin for preventing relapse by targeting cancer stem cells in gynecologic cancers; results were posted in 2018…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
A completed clinical trial update from the Gynecologic Oncology Group examining biomarkers in patients with previously untreated invasive ov…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 3]
This Phase 3 trial investigated bevacizumab with intravenous or intraperitoneal chemotherapy in stage II-III ovarian epithelial cancer, fall…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial update investigating bevacizumab with intravenous or intraperitoneal chemotherapy in stage II-III ovarian epithelial cancer, f…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: The Efficacy of Involved-field Radiation Therapy for Residual or Locoregionally Recurrent Epithelial Ovarian Cancer After Definitive Treatment; Multi-institutional Clinical Trial [NA]
A multi-institutional clinical trial evaluated the efficacy of involved-field radiation therapy for residual or locoregionally recurrent epi…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating ONT-10 in combination with varlilumab for advanced breast an…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab [NA]
This is a completed clinical trial evaluating Polyvalent Vaccine-KLH Conjugate and Opt-821 in combination with Bevacizumab for fallopian tub…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers [NA]
The clinical trial update indicates termination of a peer-to-peer support program intended to improve quality of life for gynecologic cancer…
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers [Phase 2]
Phase 2 clinical trial evaluating tasquinimod in advanced/metastatic hepatocellular, ovarian, renal cell, and gastric cancers has been compl…
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under Radiotherapy [NA]
This clinical trial update reports the completion of a study evaluating music therapy to reduce fatigue in women with breast or gynecologic …
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Salvage Ovarian FANG™ Vaccine + Carboplatinum [Phase 2]
Phase 2 trial results for Gradalis' Salvage Ovarian FANG vaccine in combination with carboplatin have been completed, with results posted fo…
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Salvage Ovarian FANG™ Vaccine + Bevacizumab [Phase 2]
Phase 2 clinical trial evaluating Salvage OVARIAN FANG vaccine in combination with bevacizumab for Stage III/IV ovarian cancer has completed…
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer [Phase 1]
Phase 1 clinical trial update evaluating the p53MVA vaccine in combination with gemcitabine hydrochloride for recurrent ovarian epithelial c…
-
CLINICAL_TRIALS trial_result · 2018-04-20Clinical Trial Update: Women's Activity and Lifestyle Study in Connecticut [Phase 3]
Phase 3 clinical trial update for the Women's Activity and Lifestyle Study in Connecticut assessing outcomes in ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2018-04-19Clinical Trial Update: A Study of Chemotherapy Treatment for Patients With Ovarian Cancer [Phase 2]
This completed Phase 2 clinical trial evaluated a chemotherapy treatment for ovarian cancer and related fallopian tube and primary peritonea…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A completed Gynecologic Oncology Group trial evaluated changes in brain function (cognitive side effects) in patients with stage I–IV ovaria…